α2-PLASMIN-INHIBITOR DEFICIENCY (MIYASATO DISEASE)

K Koie; K Ogata; Tadashi Kamiya; Junki Takamatsu; Masateru Kohakura

doi:10.1016/s0140-6736(78)91973-6

Back to search

α2-PLASMIN-INHIBITOR DEFICIENCY (MIYASATO DISEASE)

K Koie, K Ogata, Tadashi Kamiya, Junki Takamatsu, Masateru Kohakura

DOI: 10.1016/s0140-6736(78)91973-6

The Lancet

Data up to Jan 2025

Published1978

Citations88

References9

Fields

Medicine Biology Internal medicine Immunology Gastroenterology

Total Citations Per Year

Abstract

References (9)

Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.

1976 • 474 citations

Identification and Some Properties of a New Fast‐Reacting Plasmin Inhibitor in Human Plasma

1976 • 341 citations

The primary inhibitor of plasmin in human plasma

1976 • 274 citations

The behavior of alpha2-plasmin inhibitor in fibrinolytic states.

1977 • 156 citations

The α2-plasmin inhibitor levels in liver diseases

1978 • 102 citations

DISTRIBUTION OF COLD‐INSOLUBLE GLOBULIN IN PLASMA AND TISSUES*

1978 • 76 citations

Inhibition of plasminogen binding to fibrin by α2-plasmin inhibitor

1977 • 67 citations

Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.

1978 • 60 citations

Effects of α2-Plasmin Inhibitor on Fibrin Clot Lysis. Its Comparison with α2-Macroglobulin

1978 • 57 citations

Cited By (0)

Loading...